Rufus-Membere, Pamela http://orcid.org/0000-0002-8693-0457
Holloway-Kew, Kara L. http://orcid.org/0000-0001-5064-2990
Diez-Perez, Adolfo
Appelman-Dijkstra, Natasha M. http://orcid.org/0000-0001-5035-127X
Bouxsein, Mary L.
Eriksen, Erik F.
Farr, Joshua N. http://orcid.org/0000-0002-3179-6414
Khosla, Sundeep
Kotowicz, Mark A. http://orcid.org/0000-0002-8094-1411
Nogues, Xavier http://orcid.org/0000-0002-5537-1859
Rubin, Mishaela
Pasco, Julie A. http://orcid.org/0000-0002-8968-4714
Funding for this research was provided by:
National Health and Medical Research Council (299831, 628582)
Amgen-GSK OA-ANZBMS
National Institutes of Health (AR027065, R21AR067966)
Article History
Received: 5 September 2022
Accepted: 30 November 2022
First Online: 2 February 2023
Change Date: 24 February 2023
Change Type: Update
Change Details: Missing Open Access funding information has been added in the Funding Note.
Declarations
:
: All participants were drawn from studies approved by the Ethics Committees at each institution. All participants provided written informed consent.
: ADP owns shares of Active Life Scientific, Inc., the manufacturer of the RPI device. XN and NMAD organise training courses for Active Life Scientific. PRM, KLHK, MLB, EFE, FNF, SK, MAK, MR and JAP declare that they have no conflict of interest.